IgG4相关眼病生物标记物的研究进展
摘要
关键词
全文:
PDF参考
Derzko-Dzulynsky, Larissa. IgG4-related disease in the eye and ocular adnexa[J]. Current Opinion in Ophthalmology, 2017,28(6):617-622.
Zhao Z ,Mou D, Wang Z, et al. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China[J]. Arthritis Research & Therapy,2021,23(1):98.
Hiroto Tsuboi, Fumika Honda, Hiroyuki Takahashi, et al. Pathogenesis of IgG4-related disease.Comparison with Sjogren’s syndrome[J]. Mod Rheumatol, 2020,30(1):7-16.
Magliozzi, R., D. Marastoni, M. Calabrese. The BAFF/APRIL system as therapeutic target in multiple sclerosis[J]. Expert Opin Ther Targets, 2020, 24(11):1135-1145.
Kiyama K, D Kawabata, Y Hosono. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance[J]. Arthritis research & therapy, 2012,14(2):86.
Wu A, Andrew N H, Tsirbas A, et al. Rituximab for the treatment of IgG4-related orbital disease: experience from five cases[J]. Eye, 2014,29(1):122-128.
Kim, S J, Lee S U, Kang M S, et al. IgG4-related disease presenting as recurrent scleritis combined with optic neuropathy[J]. BMC Ophthalmol,2021,21(1):5.
Nishikori A, Nishimura Y, Shibata R, et al. Upregulated Expression of Activation-Induced Cytidine Deaminase in Ocular Adnexal Marginal Zone Lymphoma with IgG4-Positive Cells[J]. International journal of molecular sciences,2021,22(8):4083.
Furukawa S, Moriyama M, Tanaka A, et al. Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz’s disease[J]. Clinical Immunology,2015,156(1):9-18.
Torre E D, Mattoo H, Mahajan V S, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease[J]. Allergy,2014,69(2):269-272.
Michailidou D, Schwartz D M, Mustelin T, et al. Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy[J]. Frontiers in Immunology, 2021,12:693192.
Mohapatra S, Charilaou P, Sharma A, et al. Significance of peripheral eosinophilia for diagnosis of IgG4-related disease in subjects with elevated serum IgG4 levels[J]. Pancreatology,2020,20(1):74-78.
Zhou J, Peng Y, Peng L, et al. Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study[J]. Arthritis research & therapy,2020,22(1):255.
Culver E L, Sadler R, Bateman A C, et al. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease[J]. Clinical Gastroenterology & Hepatology,2017,15(9):1444-1452.
Zhang J, Lian M, Li B, et al. Interleukin-35 Promotes Th9 Cell Differentiation in IgG4-Related Disorders: Experimental Data and Review of the Literature[J]. Clinical Reviews in Allergy & Immunology,2021,60(1):132-145.
Hsieh S C, Shen C Y, Liao H T, et al. The Cellular and Molecular Bases of Allergy, Inflammation and Tissue Fibrosis in Patients with IgG4-related Disease[J]. International Journal of Molecular Sciences,2020,21(14):5082.
DOI: https://doi.org/10.12346/pmr.v4i3.6676
Refbacks
- 当前没有refback。